1. Home
  2. CYCC vs BMR Comparison

CYCC vs BMR Comparison

Compare CYCC & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • BMR
  • Stock Information
  • Founded
  • CYCC 1992
  • BMR 2009
  • Country
  • CYCC Malaysia
  • BMR Israel
  • Employees
  • CYCC N/A
  • BMR N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • BMR Computer Software: Prepackaged Software
  • Sector
  • CYCC Health Care
  • BMR Technology
  • Exchange
  • CYCC Nasdaq
  • BMR Nasdaq
  • Market Cap
  • CYCC 61.2M
  • BMR 59.3M
  • IPO Year
  • CYCC N/A
  • BMR 2023
  • Fundamental
  • Price
  • CYCC $0.32
  • BMR $3.11
  • Analyst Decision
  • CYCC
  • BMR
  • Analyst Count
  • CYCC 0
  • BMR 0
  • Target Price
  • CYCC N/A
  • BMR N/A
  • AVG Volume (30 Days)
  • CYCC 3.9M
  • BMR 1.0M
  • Earning Date
  • CYCC 08-13-2025
  • BMR 08-05-2025
  • Dividend Yield
  • CYCC N/A
  • BMR N/A
  • EPS Growth
  • CYCC N/A
  • BMR N/A
  • EPS
  • CYCC N/A
  • BMR N/A
  • Revenue
  • CYCC $14,000.00
  • BMR $3,064,000.00
  • Revenue This Year
  • CYCC $137.21
  • BMR $21.21
  • Revenue Next Year
  • CYCC N/A
  • BMR N/A
  • P/E Ratio
  • CYCC N/A
  • BMR N/A
  • Revenue Growth
  • CYCC N/A
  • BMR 5.33
  • 52 Week Low
  • CYCC $0.25
  • BMR $1.86
  • 52 Week High
  • CYCC $39.84
  • BMR $6.59
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 25.85
  • BMR 50.77
  • Support Level
  • CYCC $0.31
  • BMR $2.98
  • Resistance Level
  • CYCC $0.41
  • BMR $3.39
  • Average True Range (ATR)
  • CYCC 0.07
  • BMR 0.31
  • MACD
  • CYCC 0.10
  • BMR -0.05
  • Stochastic Oscillator
  • CYCC 38.57
  • BMR 15.28

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

Share on Social Networks: